A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation - Masahiro Ohira; Yuki Imaoka; Koki Sato; Koki Imaoka; Tomoaki Bekki; Takuya Yano; Ryosuke Nakano; Hiroshi Sakai; Shintaro Kuroda; Hiroyuki Tahara; Kentaro Ide; Tsuyoshi Kobayashi; et al. (PLoS ONE, 2025)